Vaccinology has accomplished substantial success in preventing a number of life-threatening infectious diseases in the last century. Nevertheless, today's vaccinologists are still facing the serious requirement for effective vaccines against pathogens that have not yet been sufficiently controlled. A promising approach to meet this requirement is naked DNA vaccine technology. However, DNA vaccine alone is not strong enough for the prophylaxis or therapy required in on-going vaccine trials.
Vaccinology has accomplished substantial success in preventing a number of life-threatening infectious diseases in the last century. Nevertheless, today's vaccinologists are still facing the serious requirement for effective vaccines against pathogens that have not yet been sufficiently controlled. A promising approach to meet this requirement is naked DNA vaccine technology. However, DNA vaccine alone is not strong enough for the prophylaxis or therapy required in on-going vaccine trials. 1 To make it stronger, we have recently established a novel approach to enhance DNA-raised immune responses 2 by using apoptosis-inducing caspases 3 ,4 based on the findings which suggest an interesting role of apoptosis in generating immune response. [5] [6] [7] Attenuated caspases induce 'bland' apoptosis, 8 which does not interfere with the expression of co-delivered antigen. By contrast, wild-type caspases induce extensive apoptosis that significantly diminishes antigen expression. Intramuscular (i.m.) injection of the plasmids co-expressing an attenuated caspase and an antigen markedly augmented antigen-specific immune responses. 2 The enhancement was biased to type 1 immune response characterized with dominant IFN-␥ and IgG2a production, 9 which is consistent with the inclination seen in DNA vaccination by i.m. injection. 10, 11 Correspondence: S Sasaki Besides i.m. injection, particle bombardment by gene gun is also a major delivery route of DNA immunization. Are gene gun-delivered caspases able to boost DNAraised immune response in the same way as i.m. injection? We herein report the immunomodulatory effect of mutant caspases for influenza DNA vaccine delivered by gene gun. Figure 1 shows the caspase dose-dependent antibody response to influenza hemagglutinin (HA). The amount of caspase DNA is varied from 0.01 to 1.0 g, while HA DNA dose is fixed at 0.1 g. Mock DNA, an empty vector, is supplemented to adjust total DNA amount to 2 g in all groups. Caspases containing intact active sites (csp2 and C2P-csp3⌬9) failed to enhance antibody response to HA. Moreover, high dose (1.0 g) caspases inhibited generation of immune response, which was obvious in the C2P-csp3⌬9 group. Considerable adjuvant effect was noted with intermediate (0.1 g) or low (0.01 g) doseattenuated caspases. C2P-csp3⌬9m was stronger than csp2m; the former showed a four-to six-fold, effect while the latter gave a three-to four-fold effect. The above findings are consistent with the results from the i.m. injection 2 that attenuated mutant caspases served as effective adjuvants while wild-type caspases failed to enhance the response. Additionally, a unique property of gene gun technology revealed an interesting facet of apoptosis inducing caspases in modulating immune response. Unlike i.m. injection, gene gun allows delivery of two separate plasmids into a single cell simply by coating gold beads with two plasmids. Another advantage of using gene gun delivery is that the ratio of antigen and caspase DNA dose can be easily altered, while the equivalent amount of DNA must be delivered by i.m. injection of dual expression vector. Interestingly, low-dose attenuated caspases were more effective than intermediate-dose in enhancing specific immune response. When high dose (1.0 g) mutant caspases were administered, no adjuvant effect was observed. A translation from these findings is that mild, but not extensive apoptosis is essential for adjuvant effect. Why is a low level of apoptosis required to enhance DNA-raised immune response?
To address this issue, we next examined the skin specimens transduced with LacZ/caspase dual expression plasmids which were designed to express both LacZ and caspase in a cell. Figure 2 demonstrates the results from X-gal staining for LacZ expression and single-stranded DNA staining for apoptotic cells. LacZ expressions were observed in the epidermis of the mouse transduced with LacZ/csp2m, LacZ/C2P-csp3⌬9m, and LacZ plasmid. However, very faint LacZ expression was seen in the mouse treated with LacZ/csp2, and no expression was detected in the mouse treated with LacZ/C2P-csp3⌬9 plasmid. To evaluate the extent of apoptosis, skin specimens were stained for single-stranded DNA. Positive cells were detected in the epidermis of the LacZ/csp2 and LacZ/C2P-csp3⌬9-transduced mouse skin (arrows). No apoptotic cells were found in the mouse treated with attenuated caspases. We considered that marginal levels of apoptosis induced by attenuated caspases cannot be detected by this histochemical staining, although very limited apoptosis by these mutant caspases was obvious in our previous experiment using Annexin staining. 2 
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Figure 2 Reporter gene expression and apoptosis detection in the mouse skin transduced with dual expression plasmids for LacZ and caspases. Indicated plasmids were delivered into abdominal skin by gene gun as described in the legend to Figure 1, and the skin was harvested 2 days following bombardment. Frozen tissue sections were fixed with 4% paraformaldehyde, and stained for ␤-galactosidase by standard X-gal staining. For detection of apoptotic cells, non-specific protein binding was blocked with 5% goat serum and by avidin-biotin blocking kit (Vector Laboratories, Burlingame, CA, USA). Then, the sections were incubated with anti-ssDNA antibody (DAKO, Glostrup, Denmark) in 1/200 dilution for 90 min. Immunoreactivities were visualized by using LSAB Kit (DAKO). Left and right column of photomicrographs are representative sections for ␤-Gal expression and apoptotic cells (arrow), respectively (Magnification ×400).
Taken together, these findings indicate that the balance between apoptosis and antigen production is maintained only in low levels of apoptosis induced by attenuated mutants. Non-attenuated caspases elicit extensive apoptosis and interfere with sufficient antigen expression to generate immune response. In this context, even with attenuated mutants, high-dose administration possibly elicits more extensive apoptosis than low-or intermediate-dose, and antigen expression might be reduced. It should be noted that only low levels of apoptosis induced by low-or intermediate-dose mutants can boost DNAraised immune response. This conclusion must be considered in a further effort to intensify DNA vaccines by apoptosis-mediated adjuvant strategy.
Antigen dose-dependent antibody response is shown in Figure 3 . In this experiment, high (1.0 g) and low (0.1 g) dose groups were arranged, and equivalent amounts of immunogen and attenuated caspases were administered. The amount of total DNA is adjusted to 2 g by supplementation with mock DNA. As expected, the magnitude of immune response was correlated with the amount of immunogen DNA. The high-dose group always yielded stronger response than the low-dose group. It was also noted that C2P-csp3⌬9m was significantly stronger than csp2m in terms of adjuvant activity. The immunoglobulin isotype profile for the caspase-adjuvanted responses was the same as for the non-adjuvanted response; gene gun inoculations raised predominantly IgG1 response (Figure 4, left panel) . The adjuvant effect of gene gun-delivered caspases on cell-mediated immune responses was evaluated with cytokine production by in vitro restimulated splenocytes measured by ELISPOT assay. Although cytokine production was measured for IFN-␥ and IL-4, only IL-4 response was detectable (Figure 4, right panel) . IFN-␥ ELISPOTs were background level regardless of caspase administration, while positive control (splenocytes stimulated with PMA and ionomycin) yielded a substantial response. This indicates that the immune response is entirely shifted to type 2 response, which is compatible with the dominant IgG1 response seen in ELISA. Another contrast between gene gun delivery and intramuscular injection is T cell subset which predominantly produces a cytokine. With gene gun delivery, CD4 T cells (measured following stimulation with class II peptides) were dominantly activated regardless of caspase use. By contrast, CD8 T cell response (measured following stimulation with class I peptide) was dominant in i.m. injection. This trend is compatible with previous findings 10, 11 and verifies that attenuated caspases change the magnitude of T cell response, but not the T cell subset predominantly activated by antigen restimulation. Again, C2P-csp3⌬9m was more efficient than csp2m in eliciting antigen-specific IL-4 production. The number of IL-4 ELISPOTs by the caspase 3 mutant was around 120, while caspase 2 mutant yielded less than 50 spots. This difference was statistically significant (P Ͻ 0.01). The superiority of caspase 3 mutant to caspase 2 mutant is preserved in both humoral and cellular response, using both g.g. delivery and i.m. injection. The mechanism corresponding to mutant caspase 3 superiority remains conjectural and adjuvant activity of other caspase family members is not yet evaluated. Further studies to assess these subjects might be necessary.
Figure 4 Immunoglobulin isotype profile (left) and IL-4 production by in vitro restimulated-splenocytes (right
The current study ensures the critical role of 'bland' apoptosis of antigen-harboring cells in enhancing immune response. We believe that apoptosis-mediated enhancement of DNA vaccines is a promising approach because of its prominent adjuvant effect, as well as its ability to kill DNA-transduced cells which cause possible genomic mutation. To evaluate the merit of this novel approach in developing next generation DNA vaccines, testing various combinations of antigens and caspases is awaited.
